Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Revance Therapeutics | RVNC | Apr 24, 2024 | 3.57 | -2.46 |
Revelation Biosciences | REVB | Apr 24, 2024 | 2.09 | +0.97 |
Revelstone Capital Acquisition A | RCAC | Apr 24, 2024 | 10.70 | 0.00 |
Revenueshares Largecap | RWL | Apr 24, 2024 | 91.05 | -0.14 |
Revenueshares Midcap | RWK | Apr 24, 2024 | 109.46 | +0.21 |
Revenueshares Smallcap | RWJ | Apr 24, 2024 | 40.51 | -0.54 |
Revenueshares Ultra Dividend Fund | RDIV | Apr 24, 2024 | 44.75 | +0.65 |
Reviva Pharmaceuticals | RVPH | Apr 24, 2024 | 3.02 | -1.31 |
Revolution Medicines | RVMD | Apr 24, 2024 | 35.59 | -1.85 |
Revolve Group A | RVLV | Apr 24, 2024 | 19.80 | +1.07 |
Revvity | RVTY | Apr 24, 2024 | 102.68 | -0.79 |
REX American Resources | REX | Apr 24, 2024 | 55.97 | -1.48 |
Rexford Industrial Realty | REXR | Apr 24, 2024 | 42.54 | -2.72 |
Rexford Industrial Realty B Pref | REXR-B | Apr 24, 2024 | 21.25 | -0.38 |
Rexford Industrial Realty C Pref | REXR-C | Apr 24, 2024 | 20.82 | -0.19 |
Reynolds Consumer Products | REYN | Apr 24, 2024 | 28.71 | +0.28 |
Rezolute | RZLT | Apr 24, 2024 | 2.89 | +1.05 |
RF Acquisition A | RFAC | Apr 24, 2024 | 10.90 | 0.00 |
RF Industries | RFIL | Apr 24, 2024 | 2.95 | -1.34 |
RGC Resources | RGCO | Apr 24, 2024 | 20.26 | +1.40 |
RH | RH | Apr 24, 2024 | 251.85 | +1.32 |
Rhinebeck Bancorp | RBKB | Apr 24, 2024 | 7.64 | 0.00 |
Rhythm Pharmaceuticals | RYTM | Apr 24, 2024 | 39.71 | -0.73 |
Ribbon Communications | RBBN | Apr 24, 2024 | 3.25 | +26.46 |
Richardson Electronics | RELL | Apr 24, 2024 | 10.08 | -2.23 |
Richmond Mutual Bank | RMBI | Apr 24, 2024 | 11.71 | +1.04 |
Richtech Robotics | RR | Apr 24, 2024 | 1.18 | -2.48 |
Rigel Pharmaceuticals | RIGL | Apr 24, 2024 | 1.13 | -1.32 |
Rigel Resource Acquisition | RRAC | Apr 24, 2024 | 11.25 | 0.00 |
Rigetti Computing | RGTI | Apr 24, 2024 | 1.15 | -3.36 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.